| |
|
|
| Name: |
BAKER BROS ADVISORS LLC |
| City: |
NEW YORK |
| State: |
NY |
| Zip: |
10021 |
| |
|
|
| Achive
data |
| View
Filing Period: |
|
|
|
|
|
|
 |
Download |
|
|
| |
| |
|
Free Registration Required For Full Results
|
|
|
| Holdings
Found :
23 |
|
View All Holdings |
Currently
Viewing:
Increased Positions |
|
|
Page 1 of 1 |
Menu
 |
Ticker |
Company Name |
Position
Rank |
New/Closed
Postion |
Last
Close |
Value |
Shares Held |
% of
Portfolio |
Value
Change |
Change In
Shares Held |
% of Company |
Industry |
|
INCY |
Incyte Corp |
1 |
- |
$52.82 |
$2,271,687,000 |
36,179,122 |
26.26% |
181,651,000 |
556 |
16.52 |
Biotechnology |
|
|
MDGL |
Madrigal Pharmaceuticals Inc |
4 |
- |
$222.26 |
$455,772,000 |
1,969,798 |
5.27% |
230,124,000 |
424,685 |
11.881 |
Diagnostic Substances |
|
|
MRTX |
Mirati Therapeutics, Inc. |
6 |
- |
$58.70 |
$242,135,000 |
4,121,440 |
2.8% |
180,725,000 |
2,711,656 |
6.157 |
Biotechnology |
|
|
KYMR |
Kymera Therapeutics, Inc. |
8 |
- |
$0.00 |
$152,656,000 |
5,995,928 |
1.76% |
86,625,000 |
1,245,528 |
9.987 |
N/A |
|
|
RVMD |
Revolution Medicines, Inc. |
9 |
- |
$35.83 |
$147,663,000 |
5,148,657 |
1.71% |
73,162,000 |
2,457,164 |
4.495 |
N/A |
|
|
ABCL |
Abcellera Biologics Inc. |
10 |
- |
$0.00 |
$130,815,000 |
22,909,753 |
1.51% |
35,304,000 |
2,146,430 |
8.511 |
N/A |
|
|
REPL |
Replimune Group Inc |
12 |
- |
$6.97 |
$80,467,000 |
9,545,336 |
0.93% |
2,133,000 |
4,967,056 |
16.85 |
N/A |
|
|
RARE |
Ultragenyx Pharmaceutical Inc |
14 |
- |
$43.38 |
$70,130,000 |
1,466,547 |
0.81% |
21,413,000 |
100,000 |
2.152 |
Restaurants |
|
|
IMTX |
Immatics N.V |
16 |
- |
$10.26 |
$61,483,000 |
5,838,853 |
0.71% |
-3,838,000 |
198,037 |
9.281 |
N/A |
|
|
DNLI |
Denali Therapeutics Inc. |
19 |
- |
$16.60 |
$55,950,000 |
2,607,196 |
0.65% |
8,666,000 |
315,193 |
2.174 |
N/A |
|
|
XENE |
Xenon Pharmaceuticals Inc. |
23 |
- |
$0.00 |
$45,769,000 |
993,679 |
0.53% |
20,093,000 |
242,040 |
1.589 |
N/A |
|
|
CERS |
Cerus Corp |
25 |
- |
$1.64 |
$42,071,000 |
19,477,339 |
0.49% |
14,143,000 |
2,237,838 |
11.653 |
Biotechnology |
|
|
EWTX |
Edgewise Therapeutics, Inc. |
29 |
- |
$0.00 |
$34,054,000 |
3,112,786 |
0.39% |
28,039,000 |
2,063,087 |
4.459 |
N/A |
|
|
SERA |
Sera Prognostics, Inc. |
30 |
- |
$9.79 |
$32,498,000 |
5,434,399 |
0.38% |
29,679,000 |
3,919,057 |
18.554 |
N/A |
|
|
BCYC |
Bicycle Therapeutics Ltd |
31 |
- |
$0.00 |
$32,370,000 |
1,790,390 |
0.37% |
15,418,000 |
946,576 |
6.087 |
N/A |
|
|
IGMS |
Igm Biosciences, Inc. |
32 |
- |
$0.00 |
$30,672,000 |
3,691,011 |
0.35% |
4,305,000 |
533,247 |
15.24 |
N/A |
|
|
VERV |
Verve Therapeutics, Inc. |
35 |
- |
$0.00 |
$23,580,000 |
1,691,530 |
0.27% |
4,797,000 |
275,000 |
2.545 |
N/A |
|
|
GRCL |
Gracell Biotechnologies Adr... |
37 |
- |
$0.00 |
$20,883,000 |
2,080,000 |
0.24% |
18,003,000 |
1,080,000 |
3.095 |
N/A |
|
|
STOK |
Stoke Therapeutics, Inc. |
44 |
- |
$0.00 |
$10,679,000 |
2,030,134 |
0.12% |
4,824,000 |
544,219 |
4.266 |
N/A |
|
|
SGMT |
Sagimet Biosciences Inc. |
52 |
- |
$3.97 |
$7,894,000 |
1,456,518 |
0.09% |
719,000 |
641,159 |
6.819 |
N/A |
|
|
TSHA |
Taysha Gene Therapies, Inc. |
57 |
- |
$0.00 |
$7,088,000 |
4,004,756 |
0.08% |
-827,000 |
1,500,000 |
10.827 |
N/A |
|
|
HOOK |
Hookipa Pharma Inc. |
58 |
- |
$0.00 |
$6,584,000 |
8,128,151 |
0.08% |
1,616,000 |
62,753 |
15.975 |
N/A |
|
|
XNCR |
Xencor Inc |
60 |
- |
$18.95 |
$5,211,000 |
245,431 |
0.06% |
2,730,000 |
122,304 |
0.37 |
Biotechnology |
|
